retatrutide phase 2 diabetes weight loss 2024 This data from 3 clinical trials for was announced yesterday at @amdiabetesassn #ADA2026 ✓ We are fortunate to be living in a time where there multiple medications which safely reduce Eli Lilly's retatrutide shows promising

Lilly noted in a press release announcing Foundayos FDA approval that adults on the highest dose of the medication lost an average of 27 pounds or 12.4% of their body weight over a period of 72 weeks

Starting Retatrutide felt like taking a leap of faith

Traditional public health efforts have focused on cancer screening, tobacco cessation and lifestyle modifications

While endocrinologists and internists still dominate prescribing, nondiabetes specialists have increased GLP1 prescribing by 900% since 2020, signaling a fundamental shift in perception and adoption as audiences expand beyond traditional prescribers

What Happens If Hunger Returns

At higher doses (8-12mg), GLP-1 activation approaches its ceiling effect